These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 4653814)
1. [Dissolution of a giant staghorn uric calculus by medical treatment]. Bouffioux C; De Leval J Acta Urol Belg; 1972 Jul; 40(3):651-9. PubMed ID: 4653814 [No Abstract] [Full Text] [Related]
2. The use of the xanthine oxidase inhibitor, allopurinol, in the control of hyperuricaemia, gout and uric acid calculi. Emmerson BT Australas Ann Med; 1967 Aug; 16(3):205-14. PubMed ID: 6056609 [No Abstract] [Full Text] [Related]
3. Treatment of uric acid urolithiasis with allopurinol: a xanthine oxidase inhibitor. Alexander S; Brendler H J Urol; 1967 Feb; 97(2):340-3. PubMed ID: 6018432 [No Abstract] [Full Text] [Related]
4. [Allopurinol in the treatment of gout and uric acid nephrolithiasis]. Zöllner N; Schattenkirchner M Dtsch Med Wochenschr; 1967 Apr; 92(14):654-60. PubMed ID: 6024539 [No Abstract] [Full Text] [Related]
8. [Physical, chemical and biological bases for the treatment and prevention of urolithiasis]. Stecki H Wiad Lek; 1973 May; 26(10):933-7. PubMed ID: 4575838 [No Abstract] [Full Text] [Related]
9. [The internal therapy of patients with uric acid containing urinary calculi]. Zöllner N Urologe; 1968; 7(1):46-50. PubMed ID: 5667553 [No Abstract] [Full Text] [Related]
10. [When and how to prescribe uricosuric agents? The need for urinary alkalinization]. Lagrue G Sem Hop Ther; 1974; 50(7-8):449-52. PubMed ID: 4445888 [No Abstract] [Full Text] [Related]
11. [The use of Allopurinol in the treatment of urinary calculi]. Frang D; Berényi M; Végh A Orv Hetil; 1972 Sep; 113(36):2167-71. PubMed ID: 5051103 [No Abstract] [Full Text] [Related]
12. [Evaluation of treatment of uric acid urolithiasis and prevention of stone formation in children]. Gadomska-Prokop K; Ryczkowska B; Tysarowska A Pediatr Pol; 1996 Aug; 71(8):685-7. PubMed ID: 8927472 [TBL] [Abstract][Full Text] [Related]
13. Prevention of recurrent uric acid and calcium oxalate stones by administration of the xanthine oxidase inhibitors Milurit 100 and Milurit 300. Schneider HJ; Brundig P; Balogh A; Traeger A; Stein G; Fünfstück R Int Urol Nephrol; 1983; 15(2):121-9. PubMed ID: 6688800 [TBL] [Abstract][Full Text] [Related]
14. Management of the stone former. Burns JR; Finlayson B Semin Urol; 1984 Feb; 2(1):34-44. PubMed ID: 6463460 [No Abstract] [Full Text] [Related]
15. Placebo versus allopurinol for recurrent urinary calculi. Smith MJ Proc Eur Dial Transplant Assoc; 1983; 20():422-6. PubMed ID: 6361753 [No Abstract] [Full Text] [Related]
17. Uric acid lithiasis: a report on 3 patients along with a study on the response to 'allopurinol' in one. Singh SM; Bajaj JS; Rao DV Indian J Med Res; 1971 Mar; 59(3):419-26. PubMed ID: 5090021 [No Abstract] [Full Text] [Related]
18. Analysis of treatment results in uric acid lithiasis with and without hyperuricemia. Alken CE; May P; Braun JS Adv Exp Med Biol; 1974; 41():535-40. PubMed ID: 4832578 [No Abstract] [Full Text] [Related]
19. A new approach to the treatment of uric acid stones with comments on xanthinuria and calculi. Silberman HR Mod Treat; 1967 May; 4(3):531-8. PubMed ID: 6045806 [No Abstract] [Full Text] [Related]
20. [Urinary calculi]. Vahlensieck W Wien Med Wochenschr; 1973 Sep; 123(39):561-6. PubMed ID: 4583923 [No Abstract] [Full Text] [Related] [Next] [New Search]